Page last updated: 2024-12-06

4',6-bis(2'imidazolinyl-4',5'-h)-2-phenylindole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4',6-bis(2'imidazolinyl-4',5'-H)-2-phenylindole: used to produce distinct fluorescent bands in human chromosomes; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID47363
CHEMBL ID164837
SCHEMBL ID362453
MeSH IDM0062844

Synonyms (15)

Synonym
6-(4,5-dihydro-1h-imidazol-2-yl)-2-(4-(4,5-dihydro-1h-imidazol-2-yl)phenyl)-1h-indole
dipi
brn 3566300
1h-indole, 6-(4,5-dihydro-1h-imidazol-2-yl)-2-(4-(4,5-dihydro-1h-imidazol-2-yl)phenyl)-
ccris 3828
4',6-diamidinophenylimidazoline
6-(4,5-dihydro-1h-imidazol-2-yl)-2-[4-(4,5-dihydro-1h-imidazol-2-yl)phenyl]-1h-indole
1h-indole, 6-(4,5-dihydro-1h-imidazol-2-yl)-2-[4-(4,5-dihydro-1h-imidazol-2-yl)phenyl]-
CHEMBL164837 ,
bdbm50378658
4',6-bis(2'imidazolinyl-4',5'-h)-2-phenylindole
64431-93-2
SCHEMBL362453
DTXSID80214688
6-(2-imidazolin-2-yl)-2-[4-(2-imidazolin-2-yl)-phenyl]indole
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Botulinum neurotoxin type A Clostridium botulinumIC50 (µMol)20.00000.50003.16927.2000AID458655
Lethal factorBacillus anthracisIC50 (µMol)49.00000.09702.85976.0000AID458657
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Molecular Functions (1)

Processvia Protein(s)Taxonomy
protein transmembrane transporter activityBotulinum neurotoxin type A Clostridium botulinum
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID53470Inhibitory dose against oncornaviral DNA polymerase activity of moloney murine leukemia virus1980Journal of medicinal chemistry, Jul, Volume: 23, Issue:7
Diaryl amidine derivatives as oncornaviral DNA polymerase inhibitors.
AID458660Inhibition of human MMP12010Journal of medicinal chemistry, Mar-11, Volume: 53, Issue:5
Synthesis and biological evaluation of botulinum neurotoxin a protease inhibitors.
AID580534Antimicrobial activity against Bacillus anthracis Sterne vegetative cells by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
Novel broad-spectrum bis-(imidazolinylindole) derivatives with potent antibacterial activities against antibiotic-resistant strains.
AID458661Inhibition of human MMP92010Journal of medicinal chemistry, Mar-11, Volume: 53, Issue:5
Synthesis and biological evaluation of botulinum neurotoxin a protease inhibitors.
AID580533Antimicrobial activity against Bacillus anthracis Sterne spores by broth microdilution method2009Antimicrobial agents and chemotherapy, Oct, Volume: 53, Issue:10
Novel broad-spectrum bis-(imidazolinylindole) derivatives with potent antibacterial activities against antibiotic-resistant strains.
AID458655Inhibition of Clostridium botulinum toxin BoNT/A light chain by FRET assay2010Journal of medicinal chemistry, Mar-11, Volume: 53, Issue:5
Synthesis and biological evaluation of botulinum neurotoxin a protease inhibitors.
AID458657Inhibition of Bacillus anthracis anthrax lethal factor by FRET assay2010Journal of medicinal chemistry, Mar-11, Volume: 53, Issue:5
Synthesis and biological evaluation of botulinum neurotoxin a protease inhibitors.
AID458659Inhibition of Clostridium botulinum toxin BoNT/B2010Journal of medicinal chemistry, Mar-11, Volume: 53, Issue:5
Synthesis and biological evaluation of botulinum neurotoxin a protease inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (50.00)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.47 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]